All Articles

Fintech PhotonPay is transforming cross-border payments for SMEs with J.P. Morgan’s Kinexys blockchain platform, slashing settlement times from days to approximately 90 seconds and challenging traditional banking models.

GATE Energy’s expansion into Vietnam signals confidence in the Asian energy market and a commitment to its unique employee-ownership structure. How is this model positioning the firm for success?

Canadian cannabis firm MediPharm Labs secures dismissal of a defamation lawsuit brought by a dissident shareholder group, revealing a contentious proxy battle and questions around business practices.

Driven by health & wellness trends, India's amino acid market is set for substantial expansion. However, reliance on imports and limited domestic production capacity pose significant challenges for sustained growth.

A local school and family-owned grocer are partnering to fight hunger in Putnam County, but behind the charitable act lies a complex landscape of need and scrutiny.

GreenPower Motor Company secures financing to scale production of its all-electric school buses, aiming to capitalize on growing demand and federal incentives driving the transition to zero-emission transportation.

A new contract to provide computing infrastructure for the Square Kilometre Array Observatory positions Atos as a key player in next-generation science, while highlighting the immense data processing and storage challenges of modern astronomy.

Public-private partnerships are driving a surge in infrastructure spending, but recent project setbacks highlight the growing complexities and financial risks involved for engineering and construction firms.

New research forecasts significant growth in India's atorvastatin market, driven by healthcare demands & economic factors, while highlighting vulnerabilities in the pharmaceutical supply chain and a crucial factual error regarding the drug's role in malaria treatment.

Award-winning LeanExhaust system signals a new era in automotive efficiency. Marelli’s breakthrough reduces vehicle weight and emissions, pushing the boundaries of sustainable mobility.

An American icon and a pickle purveyor team up for a limited-edition lighter. Is this quirky collab a sign of changing marketing trends, or a fleeting moment of viral appeal? We investigate.

The YEEDI M14 PLUS aims to redefine value in the crowded robot vacuum space, boasting advanced mopping, powerful suction, and self-maintenance features—all at a dramatically lower price point than competitors. But can it deliver on its promises?

A new report forecasts strong growth in the US hormone therapy market, driven by an aging population, but persistent supply chain disruptions and inconsistent insurance coverage threaten access for patients.

Kyrie Irving and ANTA aren’t just sponsoring youth hoops; they’re building community and challenging established brands with a grassroots strategy focused on equity and access.

A little-known tech company is making waves with a substantial aid contribution following the catastrophic Category 5 hurricane that slammed Jamaica. But who is Eightpoint, and what’s driving their response?

Once known as the world’s pharmaceutical manufacturing base, China is rapidly becoming a hotbed of drug innovation, attracting investment and reshaping the global landscape. A deep dive into the regulatory changes and growing R&D capabilities.

Facing industry headwinds, Reading International is strategically shedding assets and restructuring debt while adapting to evolving audience preferences and the ongoing streaming challenge. A deep dive into the company's performance.

A new charging depot in Rialto, CA, signals a major step forward for zero-emission trucking, backed by billions in investment and a push for sustainable energy. Can California's infrastructure keep pace?

Agence France Locale (AFL) – a bank owned by and for French local authorities – has earned a top credit rating, solidifying its role as a key driver of sustainable community investment across the nation.

A surge in clinical trials and a projected $6 billion market are driving innovation in Idiopathic Pulmonary Fibrosis (IPF) treatment, offering new hope for patients and attracting significant investment.